播放中国国产国语纯一级黄片免费看, 大鸡吧快来啊阿啊阿啊黄片在线播放, 中文精品日韩网站在线观看视频免费, 别揉我奶头~嗯~啊~一区二区三区,AV无码播放一级毛片免费古装,亚洲春色一区二区三区,91大神极品,美国一级大黄一片免费下载,午夜爽爽爽男女免费观看软件

Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(S)-(-)-1-(4-Methoxyphenyl)ethylamine, also known as (S)-(?)-4-Methoxy-α-methylbenzylamine, is a colorless liquid with significant applications in various industries due to its unique chemical properties. It is a chiral compound that plays a crucial role in the synthesis of various pharmaceuticals and organic compounds.

41851-59-6

Post Buying Request

41851-59-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

41851-59-6 Usage

Uses

Used in Pharmaceutical Synthesis:
(S)-(-)-1-(4-Methoxyphenyl)ethylamine is used as a key intermediate in the synthesis of S(+)-4-(1-phenylethylamino)quinazolines, which are important compounds in the development of pharmaceuticals targeting specific receptors in the human body. Its chiral nature ensures the selective synthesis of desired enantiomers, which is crucial for the efficacy and safety of the final drug product.
Used in Allergy Treatment:
In the field of allergy treatment, (S)-(-)-1-(4-Methoxyphenyl)ethylamine is used as a human immunoglobulin E (IgE) inhibitor. By inhibiting IgE, it can help in the management and treatment of various allergic conditions, such as asthma, allergic rhinitis, and atopic dermatitis.
Used in the Synthesis of Haloaryl-β-amino Acids:
(S)-(-)-1-(4-Methoxyphenyl)ethylamine is also employed in the synthesis of haloaryl-β-amino acids, which are valuable building blocks in the development of new pharmaceuticals and bioactive compounds.
Used in the Total Synthesis of Solanoeclepin A:
Furthermore, (S)-(-)-1-(4-Methoxyphenyl)ethylamine serves as a precursor to prepare chiral intermediates in the total synthesis of solanoeclepin A, a naturally occurring compound with potential biological activities.

Check Digit Verification of cas no

The CAS Registry Mumber 41851-59-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,8,5 and 1 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 41851-59:
(7*4)+(6*1)+(5*8)+(4*5)+(3*1)+(2*5)+(1*9)=116
116 % 10 = 6
So 41851-59-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H13NO/c1-7(10)8-3-5-9(11-2)6-4-8/h3-7H,10H2,1-2H3/t7-/m0/s1

41851-59-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (M1512)  (S)-(-)-1-(4-Methoxyphenyl)ethylamine  >98.0%(GC)(T)

  • 41851-59-6

  • 5g

  • 570.00CNY

  • Detail
  • TCI America

  • (M1512)  (S)-(-)-1-(4-Methoxyphenyl)ethylamine  >98.0%(GC)(T)

  • 41851-59-6

  • 25g

  • 1,680.00CNY

  • Detail
  • Alfa Aesar

  • (L16322)  (S)-(-)-1-(4-Methoxyphenyl)ethylamine, ChiPros 99+%, ee 98%   

  • 41851-59-6

  • 1g

  • 284.0CNY

  • Detail
  • Alfa Aesar

  • (L16322)  (S)-(-)-1-(4-Methoxyphenyl)ethylamine, ChiPros 99+%, ee 98%   

  • 41851-59-6

  • 5g

  • 655.0CNY

  • Detail
  • Alfa Aesar

  • (L16322)  (S)-(-)-1-(4-Methoxyphenyl)ethylamine, ChiPros 99+%, ee 98%   

  • 41851-59-6

  • 25g

  • 2538.0CNY

  • Detail
  • Aldrich

  • (95889)  (S)-(−)-4-Methoxy-α-methylbenzylamine  ≥98.0% (sum of enantiomers, GC)

  • 41851-59-6

  • 95889-5G-F

  • 996.84CNY

  • Detail
  • Aldrich

  • (95889)  (S)-(−)-4-Methoxy-α-methylbenzylamine  ≥98.0% (sum of enantiomers, GC)

  • 41851-59-6

  • 95889-25G-F

  • 3,428.10CNY

  • Detail
  • Aldrich

  • (726656)  (S)-(−)-4-Methoxy-α-methylbenzylamine  ChiPros®, produced by BASF, 99%

  • 41851-59-6

  • 726656-25G

  • 1,653.21CNY

  • Detail
  • Aldrich

  • (726656)  (S)-(−)-4-Methoxy-α-methylbenzylamine  ChiPros®, produced by BASF, 99%

  • 41851-59-6

  • 726656-100G

  • 5,007.60CNY

  • Detail

41851-59-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-(-)-1-(4-Methoxyphenyl)ethylamine

1.2 Other means of identification

Product number -
Other names (S)-1-(4-Methoxyphenyl)ethanamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:41851-59-6 SDS

41851-59-6Relevant articles and documents

Engineering the large pocket of an (S)-selective transaminase for asymmetric synthesis of (S)-1-amino-1-phenylpropane

Liu, He,Wang, Hualei,Wei, Dongzhi,Xie, Youyu,Xu, Feng,Xu, Xiangyang,Yang, Lin

, p. 2461 - 2470 (2021/04/22)

Amine transaminases offer an environmentally benign chiral amine asymmetric synthesis route. However, their catalytic efficiency towards bulky chiral amine asymmetric synthesis is limited by the natural geometric structure of the small pocket, representing a great challenge for industrial applications. Here, we rationally engineered the large binding pocket of an (S)-selective ?-transaminase BPTA fromParaburkholderia phymatumto relieve the inherent restriction caused by the small pocket and efficiently transform the prochiral aryl alkyl ketone 1-propiophenone with a small substituent larger than the methyl group. Based on combined molecular docking and dynamic simulation analyses, we identified a non-classical substrate conformation, located in the active site with steric hindrance and undesired interactions, to be responsible for the low catalytic efficiency. By relieving the steric barrier with W82A, we improved the specific activity by 14-times compared to WT. A p-p stacking interaction was then introduced by M78F and I284F to strengthen the binding affinity with a large binding pocket to balance the undesired interactions generated by F44. T440Q further enhanced the substrate affinity by providing a more hydrophobic and flexible environment close to the active site entry. Finally, we constructed a quadruple variant M78F/W82A/I284F/T440Q to generate the most productive substrate conformation. The 1-propiophenone catalytic efficiency of the mutant was enhanced by more than 470-times in terms ofkcat/KM, and the conversion increased from 1.3 to 94.4% compared with that of WT, without any stereoselectivity loss (ee > 99.9%). Meanwhile, the obtained mutant also showed significant activity improvements towards various aryl alkyl ketones with a small substituent larger than the methyl group ranging between 104- and 230-fold, demonstrating great potential for the efficient synthesis of enantiopure aryl alkyl amines with steric hindrance in the small binding pocket.

New chiral stationary phases for liquid chromatography based on small molecules: Development, enantioresolution evaluation and chiral recognition mechanisms

Phyo, Ye' Zaw,Teixeira, Joana,Tiritan, Maria Elizabeth,Cravo, Sara,Palmeira, Andreia,Gales, Luís,Silva, Artur M.S.,Pinto, Madalena M.M.,Kijjoa, Anake,Fernandes, Carla

, p. 81 - 97 (2019/11/28)

Recently, we reported the development of new chiral stationary phases (CSPs) for liquid chromatography (LC) based on chiral derivatives of xanthones (CDXs). Based on the most promising CDX selectors, 12 new CSPs were successfully prepared starting from suitable functionalized small molecules including xanthone and benzophenone derivatives. The chiral selectors comprising one, two, three, or four chiral moieties were covalently bonded to a chromatographic support and further packed into LC stainless-steel columns (150?×?2.1?mm I.D.). The enantioselective performance of the new CSPs was evaluated by LC using different classes of chiral compounds. Specificity for enantioseparation of some CDXs was observed in the evaluation of the new CSPs. Besides, assessment of chiral recognition mechanisms was performed by computational studies using molecular docking approach, which are in accordance with the chromatographic parameters. X-Ray analysis was used to establish a chiral selector 3D structure.

Preparation of chiral primary amine through asymmetric reductive amination of simple ketone under catalytic action of ruthenium-diphosphine catalyst

-

Paragraph 0077-0079, (2019/07/04)

The invention relates to a method for preparing chiral primary amine. The method comprises the steps: performing a hydrogenation reductive amination reaction on simple ketone and an ammonium salt RCOONH4 under the action of a ruthenium-chiral diphosphine catalyst, then adding an acid, performing heating for hydrolysis, and adopting a one-pot method to prepare the chiral primary amine. The method has the advantages of good universality of the substrate, high reaction efficiency and the like.

In Vitro and in Vivo One-Pot Deracemization of Chiral Amines by Reaction Pathway Control of Enantiocomplementary ω-Transaminases

Han, Sang-Woo,Jang, Youngho,Shin, Jong-Shik

supporting information, p. 6945 - 6954 (2019/08/26)

Biocatalytic cascade conversion of racemic amines into optically pure ones using enantiocomplementary ω-transaminases (ω-TAs) has been developed by thermodynamic and kinetic control of reaction pathways where 12 competing reactions occur with pyruvate and isopropylamine used as cosubstrates. Thermodynamic control was achieved under reduced pressure for selective removal of a coproduct (i.e., acetone), leading to elimination of six undesirable reactions. Engineered orthogonality in substrate specificities of ω-TAs was exploited for kinetic control, enabling suppression of four additional reactions. Taken together, the net reaction pathway could be directed to two desired reactions (i.e., oxidative deamination of R-amine and reductive amination of the resulting ketone into antipode S-amine). This strategy afforded one-pot deracemization of various chiral amines with >99% eeS and 85-99% reaction yields of the resulting S-amine products. The in vitro cascade reaction could be successfully implemented in a live microbe using glucose or l-threonine as a cheap amino acceptor precursor, demonstrating a synthetic metabolic pathway enabling deracemization of chiral amines which has never been observed in living organisms.

Asymmetric Synthesis of Chiral Primary Amines by Ruthenium-Catalyzed Direct Reductive Amination of Alkyl Aryl Ketones with Ammonium Salts and Molecular H2

Tan, Xuefeng,Gao, Shuang,Zeng, Weijun,Xin, Shan,Yin, Qin,Zhang, Xumu

supporting information, p. 2024 - 2027 (2018/02/19)

A ruthenium/C3-TunePhos catalytic system has been identified for highly efficient direct reductive amination of simple ketones. The strategy makes use of ammonium acetate as the amine source and H2 as the reductant and is a user-friendly and operatively simple access to industrially relevant primary amines. Excellent enantiocontrol (>90% ee for most cases) was achieved with a wide range of alkyl aryl ketones. The practicability of this methodology has been highlighted by scalable synthesis of key intermediates of three drug molecules. Moreover, an improved synthetic route to the optimal diphosphine ligand C3-TunePhos is also presented.

Evaluation of the Edman degradation product of vancomycin bonded to core-shell particles as a new HPLC chiral stationary phase

Hellinghausen, Garrett,Lopez, Diego A.,Lee, Jauh T.,Wang, Yadi,Weatherly, Choyce A.,Portillo, Abiud E.,Berthod, Alain,Armstrong, Daniel W.

, p. 1067 - 1078 (2018/08/01)

A modified macrocyclic glycopeptide-based chiral stationary phase (CSP), prepared via Edman degradation of vancomycin, was evaluated as a chiral selector for the first time. Its applicability was compared with other macrocyclic glycopeptide-based CSPs: TeicoShell and VancoShell. In addition, another modified macrocyclic glycopeptide-based CSP, NicoShell, was further examined. Initial evaluation was focused on the complementary behavior with these glycopeptides. A screening procedure was used based on previous work for the enantiomeric separation of 50 chiral compounds including amino acids, pesticides, stimulants, and a variety of pharmaceuticals. Fast and efficient chiral separations resulted by using superficially porous (core-shell) particle supports. Overall, the vancomycin Edman degradation product (EDP) resembled TeicoShell with high enantioselectivity for acidic compounds in the polar ionic mode. The simultaneous enantiomeric separation of 5 racemic profens using liquid chromatography-mass spectrometry with EDP was performed in approximately 3?minutes. Other highlights include simultaneous liquid chromatography separations of rac-amphetamine and rac-methamphetamine with VancoShell, rac-pseudoephedrine and rac-ephedrine with NicoShell, and rac-dichlorprop and rac-haloxyfop with TeicoShell.

Enantioselective synthesis of amines via reductive amination with a dehydrogenase mutant from Exigobacterium sibiricum: Substrate scope, co-solvent tolerance and biocatalyst immobilization

L?we, Jana,Ingram, Aaron A.,Gr?ger, Harald

, p. 1387 - 1392 (2018/03/21)

In recent years, the reductive amination of ketones in the presence of amine dehydrogenases emerged as an attractive synthetic strategy for the enantioselective preparation of amines starting from ketones, an ammonia source, a reducing reagent and a cofactor, which is recycled in situ by means of a second enzyme. Current challenges in this field consists of providing a broad synthetic platform as well as process development including enzyme immobilization. In this contribution these issues are addressed. Utilizing the amine dehydrogenase EsLeuDH-DM as a mutant of the leucine dehydrogenase from Exigobacterium sibiricum, a range of aryl-substituted ketones were tested as substrates revealing a broad substrate tolerance. Kinetics as well as inhibition effects were also studied and the suitability of this method for synthetic purpose was demonstrated with acetophenone as a model substrate. Even at an elevated substrate concentration of 50 mM, excellent conversion was achieved. In addition, the impact of water-miscible co-solvents was examined, and good activities were found when using DMSO of up to 30% (v/v). Furthermore, a successful immobilization of the EsLeuDH-DM was demonstrated utilizing a hydrophobic support and a support for covalent binding, respectively, as a carrier.

Application of “Smart” Amine Donors for Rapid Screening and Scale-Up of Transaminase-Mediated Biotransformations

Gomm, Andrew,Grigoriou, Stylianos,Peel, Christopher,Ryan, James,Mujtaba, Nafees,Clarke, Thomas,Kulcinskaja, Evelina,O'Reilly, Elaine

supporting information, p. 5282 - 5284 (2018/09/14)

The “smart” amine donors o-xylylenediamine and cadaverine were employed for the rapid screening of a large ketone library and subsequent preparative-scale synthesis of selected compounds using a commercially available amine transaminase, ATA256. The methodology enables both screening and preparative-scale biotransformations to be performed with a single enzyme and simplifies the generation of sp3-rich small-molecule libraries.

Mapping the substrate scope of monoamine oxidase (MAO-N) as a synthetic tool for the enantioselective synthesis of chiral amines

Herter, Susanne,Medina, Florian,Wagschal, Simon,Benha?m, Cyril,Leipold, Friedemann,Turner, Nicholas J.

, p. 1338 - 1346 (2017/10/06)

A library of 132 racemic chiral amines (α-substituted methylbenzylamines, benzhydrylamines, 1,2,3,4-tetrahydronaphthylamines (THNs), indanylamines, allylic and homoallylic amines, propargyl amines) was screened against the most versatile monoamine oxidase (MAO-N) variants D5, D9 and D11. MAO-N D9 exhibited the highest activity for most substrates and was applied to the deracemisation of a comprehensive set of selected primary amines. In all cases, excellent enantioselectivity was achieved (e.e. >99%) with moderate to good yields (55–80%). Conditions for the deracemisation of primary amines using a MAO-N/borane system were further optimised using THN as a template addressing substrate load, nature of the enzyme preparation, buffer systems, borane sources, and organic co-solvents.

Mechanism-Guided Engineering of ω-Transaminase to Accelerate Reductive Amination of Ketones

Han, Sang-Woo,Park, Eul-Soo,Dong, Joo-Young,Shin, Jong-Shik

, p. 1732 - 1740 (2015/06/02)

Asymmetric reductive amination of ketones using ω-transaminases (ω-TAs) offers a promising alternative to the chemocatalytic synthesis of chiral amines. One fundamental challenge to the biocatalytic strategy is the very low enzyme activities for most ketones compared with native substrates (i.e., cat/KM for acetophenone). The W58L mutant afforded an efficient synthesis of enantiopure amines (i.e., >99% ee) using isopropylamine as an amino donor.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 41851-59-6